Anxiety disorders / PTSD - OPEN Foundation

Trauma Interventions using Mindfulness Based Extinction and Reconsolidation (TIMBER) psychotherapy prolong the therapeutic effects of single ketamine infusion on post-traumatic stress disorder and comorbid depression: a pilot randomized, placebo-controlled, crossover clinical trial

Pradhan, B. K., Wainer, I. W., Moaddel, R., Torjman, M. C., Goldberg, M., Sabia, M., ... & Pumariega, A. J. | Asia Pacific Journal of Clinical Trials: Nervous System Diseases | 2 August 2017

Psychotherapy with Adjuvant use of Serotonergic Psychoactive Substances: Possibilities and Challenges

Majić, T., Jungaberle, H., Schmidt, T. T., Zeuch, A., Hermle, L., & Gallinat, J. | Fortschritte der Neurologie-Psychiatrie | 2 August 2017

Posttraumatic Stress Disorder: An Integrated Overview of the Neurobiological Rationale for Pharmacology

Kelmendi, B., Adams, T. G., Southwick, S., Abdallah, C. G., & Krystal, J. H. | Clinical Psychology: Science and Practice | 18 July 2017

Cancer at the Dinner Table: Experiences of Psilocybin-Assisted Psychotherapy for the Treatment of Cancer-Related Distress

Swift, T. C., Belser, A. B., Agin-Liebes, G., Devenot, N., Terrana, S., Friedman, H. L., ... & Ross, S. | Journal of Humanistic Psychology | 14 June 2017

Therapeutic effect of increased openness: Investigating mechanism of action in MDMA-assisted psychotherapy

Wagner, M. T., Mithoefer, M. C., Mithoefer, A. T., MacAulay, R. K., Jerome, L., Yazar-Klosinski, B., & Doblin, R. | Journal of Psychopharmacology | 1 June 2017

Monoamine Oxidase Inhibitors—Revisiting a Therapeutic Principle

Entzeroth, M., & Ratty, A. K. | Open Journal of Depression | 1 May 2017

Ketamine’s dose-related effects on anxiety symptoms in patients with treatment refractory anxiety disorders

Glue, P., Medlicott, N. J., Harland, S., Neehoff, S., Anderson-Fahey, B., Le Nedelec, M., ... & McNaughton, N. | Journal of Psychopharmacology | 26 April 2017

Anxiety, panic, and hopelessness during and after ritual ayahuasca intake in a woman with generalized anxiety disorder: A case report

dos Santos, R. G., Osório, F. L., Crippa, J. A. S., & C. Hallak, J. E. | Journal of Psychedelic Studies | 24 April 2017

“Being with a Buddha”: A Case Report of Methoxetamine Use in a United States Veteran with PTSD

Striebel, J. M., Nelson, E. E., & Kalapatapu, R. K. | Case reports in psychiatry | 29 January 2017

Prophylactic Ketamine Attenuates Learned Fear

McGowan, J. C., LaGamma, C. T., Lim, S. C., Tsitsiklis, M., Neria, Y., Brachman, R. A., & Denny, C. A. | Neuropsychopharmacology | 27 January 2017

Clinical potential of psilocybin as a treatment for mental health conditions

Daniel, J., & Haberman, M. | Mental Health Clinician | 1 January 2017

Ketamine accelerates fear extinction via mTORC1 signaling

Girgenti, M. J., Ghosal, S., LoPresto, D., Taylor, J. R., & Duman, R. S. | Neurobiology of Disease | 30 December 2016

Conducting PTSD clinical trials on a Schedule I drug: MDMA

Knopf, A. | Alcoholism & Drug Abuse Weekly | 12 December 2016

Psilocybin: promising results in double-blind trials require confirmation by real-world evidence

Breckenridge, A., & Grobbee, D. E. | Journal of psychopharmacology | 6 December 2016

Psilocybin-assisted psychotherapy for dying cancer patients – aiding the final trip

Spiegel, D. | Journal of psychopharmacology | 6 December 2016

Psilocybin for depression and anxiety associated with life-threatening illnesses

McCorvy, J. D., Olsen, R. H., & Roth, B. L. | Journal of psychopharmacology | 6 December 2016

The role of psychedelics in palliative care reconsidered: A case for psilocybin

Kelmendi, B., Corlett, P., Ranganathan, M., D'Souza, C., & Krystal, J. H. | Journal of psychopharmacology | 1 December 2016

Psilocybin and palliative end-of-life care

Shelton, R. C., & Hendricks, P. S. | Journal of Psychopharmacology | 1 December 2016

Psilocybin in end of life care: Implications for further research

Summergrad, P. | Journal of Psychopharmacology | 1 December 2016

Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial

Griffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., ... & Klinedinst, M. A. | Journal of Psychopharmacology | 1 December 2016

Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial

Ross, S., Bossis, A., Guss, J., Agin-Liebes, G., Malone, T., Cohen, B., ... & Su, Z. | Journal of Psychopharmacology | 1 December 2016